Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: A feasibility study

To investigate the feasibility of combined dynamic contrast enhanced (DCE) and magnetic resonance spectroscopy (MRS) in evaluating breast lesions.

[1]  T. E. Hinds.  Diseases , 2021, Modeling Biological Systems.

[2]  Wei Huang,et al.  Detection of breast malignancy: diagnostic MR protocol for improved specificity. , 2004, Radiology.

[3]  D. Bluemke,et al.  Proton magnetic resonance spectroscopic imaging of human breast cancer: A preliminary study , 2004, Journal of magnetic resonance imaging : JMRI.

[4]  Robert E. Lenkinski,et al.  The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy , 2001, Breast Cancer Research and Treatment.

[5]  Peter B Barker,et al.  Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. , 2003, Radiology.

[6]  Sung-Hwan Park,et al.  In vivo 1H-MRS evaluation of malignant and benign breast diseases. , 2003, Breast.

[7]  R. Lenkinski,et al.  Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. , 2002, Journal of the National Cancer Institute.

[8]  Hellmut Merkle,et al.  Eliminating spurious lipid sidebands in 1H MRS of breast lesions , 2002, Magnetic resonance in medicine.

[9]  N. Debruhl,et al.  Volume‐localized two‐dimensional correlated magnetic resonance spectroscopy of human breast cancer , 2001, Journal of magnetic resonance imaging : JMRI.

[10]  D. Yeung,et al.  Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results. , 2001, Radiology.

[11]  M D Schnall,et al.  Update of breast MR imaging architectural interpretation model. , 2001, Radiology.

[12]  J. K. Smith,et al.  Effects of contrast material on single-volume proton MR spectroscopy. , 2000, AJNR. American journal of neuroradiology.

[13]  R A Knight,et al.  Unsupervised segmentation of multiparameter MRI in experimental cerebral ischemia with comparison to T2, diffusion, and ADC MRI parameters and histopathological validation , 2000, Journal of magnetic resonance imaging : JMRI.

[14]  Hamid Soltanian-Zadeh,et al.  Identification of cerebral ischemic lesions in rat using eigenimage filtered magnetic resonance imaging , 1999, Brain Research.

[15]  I. Gribbestad,et al.  Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.

[16]  D. Peck,et al.  Registration and warping of magnetic resonance images to histological sections. , 1999, Medical physics.

[17]  B. Sitter,et al.  Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. , 1999, Anticancer research.

[18]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[19]  S G Orel,et al.  Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time-signal intensity curves an accurate predictor? , 1999, Radiology.

[20]  N. Jagannathan,et al.  ASSESSMENT OF THE THERAPEUTIC RESPONSE OF HUMAN BREAST CARCINOMA USING IN VIVO VOLUME LOCALIZED PROTON MAGNETIC RESONANCE SPECTROSCOPY , 1999 .

[21]  Z. Bhujwalla,et al.  Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.

[22]  M. Oudkerk,et al.  1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. , 1998, Magnetic resonance imaging.

[23]  I. Gribbestad,et al.  In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil , 1998, Journal of magnetic resonance imaging : JMRI.

[24]  R. Lenkinski,et al.  Human breast lesions: characterization with proton MR spectroscopy. , 1998, Radiology.

[25]  T E Conturo,et al.  Contrast‐agent phase effects: An experimental system for analysis of susceptibility, concentration, and bolus input function kinetics , 1997, Magnetic resonance in medicine.

[26]  K. Muller,et al.  Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. , 1997, AJNR. American journal of neuroradiology.

[27]  M D Schnall,et al.  Breast MR imaging: interpretation model. , 1997, Radiology.

[28]  J Kurhanewicz,et al.  Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.

[29]  L J van Erning,et al.  MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. , 1994, Radiology.

[30]  M D Schnall,et al.  Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. , 1994, Radiology.

[31]  P. V. van Zijl,et al.  Proton magnetic resonance spectroscopy of small regions (1 mL) localized inside superficial human tumors. A clinical feasibility study , 1990, NMR in biomedicine.

[32]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[33]  J P Windham,et al.  Eigenimage Filtering in MR Imaging , 1988, Journal of computer assisted tomography.

[34]  D Matthaei,et al.  1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.

[35]  A Haase,et al.  1H NMR chemical shift selective (CHESS) imaging , 1985 .

[36]  J. Clarke,et al.  Medicine , 1907, Bristol medico-chirurgical journal.